| Fri, Nov 20, 2009 | | • | Biotech Stock Mailbag: FDA Playbook
at TheStreet.com (Fri, Nov 20)
| | Wed, Nov 18, 2009 | | • | Trading Review for Cerus Corp. Issued by Beacon Equity
GlobeNewswire (Wed, Nov 18)
| | Tue, Nov 17, 2009 | | • | Biotech Stocks: Alkermes gains; Cerus, InterMune tumble
at MarketWatch (Tue, Nov 17)
| | • | CERUS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Tue, Nov 17)
| | • | Playboy, Helicos: Early Volume Plays
at TheStreet.com (Tue, Nov 17)
| | • | Cerus Corporation Receives FDA Blood Products Advisory Committee Guidance for Proposed INTERCEPT Blood System Phase III Trial Design
Business Wire (Tue, Nov 17)
| | Mon, Nov 16, 2009 | | • | Cerus Corporation Stock Trading Halted; FDA Blood Products Advisory Committee to Review and Discuss Proposed Phase III Clinical Trial Design for the INTERCEPT Blood System
Business Wire (Mon, Nov 16)
| | Sun, Nov 15, 2009 | | • | Short Blood Supply Means Long Outlook for Cerus
at Seeking Alpha (Sun, Nov 15)
| | Fri, Nov 13, 2009 | | • | CERUS CORP Financials
EDGAR Online Financials (Fri, Nov 13)
| | Fri, Nov 6, 2009 | | • | CERUS CORP Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Nov 6)
| | Fri, Oct 30, 2009 | | • | CERUS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to Rights of Securit
EDGAR Online (Fri, Oct 30)
| | Thu, Oct 29, 2009 | | • | Cerus Earnings Call scheduled for 4:15 pm ET today
CCBN (Thu, Oct 29)
| | • | CERUS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Thu, Oct 29)
| | • | Cerus Corporation Announces Third Quarter Financial Results
Business Wire (Thu, Oct 29)
| | • | Q3 2009 Cerus Earnings Release - After Market Close
CCBN (Thu, Oct 29)
| | Tue, Oct 20, 2009 | | • | CEO Interview: Cerus Corporation - Claus Glassell
Wall Street Transcript (Tue, Oct 20)
| | Mon, Oct 12, 2009 | | • | Cerus to Release Third Quarter Results on October 29, 2009
Business Wire (Mon, Oct 12)
| | Tue, Sep 29, 2009 | | • | Cerus to Present Proposal for INTERCEPT Platelet US Phase III Clinical Trial at November BPAC Meeting
Business Wire (Tue, Sep 29)
| | Thu, Aug 20, 2009 | | • | CERUS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
EDGAR Online (Thu, Aug 20)
| | Wed, Aug 19, 2009 | | • | CERUS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Wed, Aug 19)
|
Add CERS News to My Yahoo!:
 
| |
|
0.51% Nasdaq 
0.034 (1.80%) 
Headlines
